Key Highlights
- Loyal closes $33.5M Series B financing to expand customer base and product development.
- Chad Mallory steps down as Chairman and CEO, transitions to Senior Advisor role.
- Saurabh Sinha appointed Chairman of the Board of Directors.
- Mark Hipp joins the Board, bringing expertise in high-growth tech businesses.
Source: Business Wire
Notable Quotes
- “Loyal fills a critical gap in consumer care navigation and represents a huge opportunity to improve the lives of patients and the healthcare experience for all.” — Saurabh Sinha, Chairman of the Board at Loyal
- “This moment is about putting the right capital, people and plan together to build on the initial vision and achievements of Chad and the broader Loyal team.” — James Olsen, Founder and Managing Partner at Concord Health Partners
- “My vision from day one at Loyal was to help patients navigate their way to better care. I’m hopeful Loyal’s next phase can help even more patients lead their healthiest lives.” — Chad Mallory, Founder at Loyal
SoHC's Take
The successful closing of Loyal’s $33.5M Series B financing marks a significant milestone in the company’s journey towards enhancing digital patient engagement. With strategic leadership changes and the infusion of capital, Loyal is well-positioned to scale its operations, expand its customer base, and further develop its innovative platform. The appointment of industry veterans like Saurabh Sinha and Mark Hipp to the Board underscores the company’s commitment to growth and excellence in healthcare technology. Loyal’s platform, which consolidates disparate technology stacks to improve efficiencies and patient access, aligns perfectly with the evolving needs of health systems, making it a critical player in the healthcare sector.
Related

Goldman Sachs Asset Management’s “West Street Life Sciences I” Fund Closes at $650 Million, Marking a Pioneering Move in Life Sciences Investment
Key Highlights Exceeding Expectations: West Street Life Sciences I closes above target with $650 million in equity commitments from a diverse global investor base.Expert Leadership: Amit Sinha spearheads the Life Sciences Investing Group, leveraging decades of sector experience and extensive Goldman Sachs resources.Innovative Investment Focus: The fund targets growth-oriented private…

Glooko Secures $100M Series F Funding and Appoints Mike Alvarez as CEO
Key Highlights Glooko raises $100M in Series F funding led by Georgian, with participation from Health Catalyst Capital and Canaan.Mike Alvarez appointed as CEO, bringing over two decades of healthcare leadership experience.Financing to drive product expansion in data insights, device integration, and chronic condition support.Glooko aims to accelerate global digital healthcare platform…

MedGenome Appoints Dr. Amit Kakar as Chairman of the Board
Key Highlights Dr. Amit Kakar appointed as Chairman of MedGenome Board. Succeeds Dr. Felix Olale, who now focuses on growing MedGenome’s US business. Dr. Kakar brings 30+ years of healthcare and life sciences experience. Previously held key leadership roles at Novo Holdings and GE Healthcare. MedGenome remains committed to global health and genomic innovation. Source: PR Newswire Notable Quotes…